[Incidence of pulmonary thromboembolism in patients with COVID-19 pneumonia].

Background: COVID-19 disease is an infectious pathology which causes severe respiratory syndrome and it is caused by SARS-CoV-2. On the other hand, pulmonary thromboembolism is one of the most serious and insidious complications, although with a real incidence that is still unknown, especially in patients with COVID-19 pneumonia. Therefore, it is imperative to carry out research to know more information, as well as the relationship it could have with other comorbidities (the most frequent in our population) in order to establish early diagnosis and proper therapy.

Objective: To determine the incidence of pulmonary thromboembolism by angiotomography in patients with COVID-19 pneumonia.

Material and methods: An analytical, observational, longitudinal, single-center, retrospective and homodemic study was carried out. A total of 71 patients from a public hospital located in the city of Puebla, Mexico, were included.

Results: It was determined a cumulative incidence of 0.09 of the patients studied. Male patients were the most affected, with an average age of 65 years. The trunk of the pulmonary artery was the most affected topographic site. Likewise, the most associated comorbidity was diabetes mellitus.

Conclusions: There was a similar incidence to that obtained in studies carried out in other parts of the world.